C12N11/084

CARRIER INCLUDING AMMONIUM OXIDIZING BACTERIA IMMOBILIZED THEREIN AND METHOD FOR PREPARING SAME

Disclosed is a method for preparing the same. The method for preparing a carrier including ammonium oxidizing bacteria immobilized therein includes: preparing a PVA-alginate mixed solution containing PVA mixed with alginate; adding sludge containing ammonium oxidizing bacteria and sodium bicarbonate (NaHCO.sub.3) to the PVA-alginate mixed solution to obtain a foaming-beading solution; and dropping the foaming-beading solution to a saturated boric acid solution to obtain beads including sludge immobilized therein, wherein sodium bicarbonate (NaHCO.sub.3) is decomposed to produce carbon dioxide (CO.sub.2) which is discharged to the exterior of the beads to form pores in the beads, when the foaming-beading solution is dropped to the saturated boric acid solution to obtain beads including sludge immobilized therein.

BIOLOGICAL FILLER COMPRISING 1,5-DIHYDROXYANTHRAQUINONE AND THIOBACILLUS DENITRIFICANS POPULATION AND METHOD OF USING THE SAME FOR NITROGEN REMOVAL FROM WASTEWATER

A biological filler includes an embedding agent and an embedded complex. The embedded complex includes a scallop shell powder, 1,5-dihydroxyanthraquinone, and Thiobacillus denitrificans. The embedding agent includes a poly(vinyl alcohol)-sodium alginate blend membrane and a crosslinked composite membrane. The embedded complex is embedded by the embedded agent.

CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATE

Disclosed herein relates to biopharmaceuticals, and more particularly to a continuous flow method for preparing (R)-3-hydroxy-5-hexenoate. Carbonyl reductase and isopropanol dehydrogenase are co-immobilized onto an inert solid medium simultaneously to prepare a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, which is then filled into a microchannel reactor of the micro reaction system. A solution containing substrate 3-carbonyl-5-hexenoate is subsequently pumped into the microchannel reactor to perform an asymmetric carbonyl reduction reaction to obtain (R)-3-hydroxy-5-hexenoate.

CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATE

Disclosed herein relates to biopharmaceuticals, and more particularly to a continuous flow method for preparing (R)-3-hydroxy-5-hexenoate. Carbonyl reductase and isopropanol dehydrogenase are co-immobilized onto an inert solid medium simultaneously to prepare a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, which is then filled into a microchannel reactor of the micro reaction system. A solution containing substrate 3-carbonyl-5-hexenoate is subsequently pumped into the microchannel reactor to perform an asymmetric carbonyl reduction reaction to obtain (R)-3-hydroxy-5-hexenoate.

Detergents and Compositions with Enzymatic Polymer Particles

The present invention relates to an enzyme composition comprising enzyme containing polymer particles, which is useful for liquid laundry detergent compositions. In these enzyme containing particles, the particles comprise at least one enzyme, and at least one polymer, which is a hydrophobic modified polyvinyl alcohol.

Particle delivery via small-scale morphology materials for antibacterial applications

Disclosed herein is a particle delivery system comprising electrospun nanofiber comprised of coaxial fiber with a microfluidic core. Iron-doped apatite nanoparticles (IDANPs) have demonstrated a unique influence over phage killing of bacteria, whereby, IDANP-exposed bacterial cultures experience 2× the bacterial death as controls. IDANPs consist of hydroxyapatite (HA) doped with iron. HA is a mineral known to be biocompatible and analogous to the inorganic constituent of mammalian bone and teeth and has been approved by the Food and Drug Administration (FDA) for many applications in medicine and dentistry. Previous work has shown that for IDANPs to enhance antibacterial activity of phage to the greatest extent, bacterial cultures should be exposed to IDANPs for 1 hr prior to phage introduction. Biocompatible polymer materials which encase IDANPs and/or phage can be used to disseminate IDANPs and/or phage in a controlled manner into a physiological system for treatment of bacterial infection. When components of said materials contain micro- or nano-scale components, high surface-to-volume ratio for treatment delivery is garnered.

Biological filler comprising 1,5-dihydroxyanthraquinone and thiobacillus denitrificans population and method of using the same for nitrogen removal from wastewater

A biological filler includes an embedding agent and an embedded complex. The embedded complex includes a scallop shell powder, 1,5-dihydroxyanthraquinone, and Thiobacillus denitrificans. The embedding agent includes a poly(vinyl alcohol)-sodium alginate blend membrane and a crosslinked composite membrane. The embedded complex is embedded by the embedded agent.

Encapsulated microorganisms and methods of using same

A dehydrated composition containing a particle encapsulating one or more microorganisms is provided. The composition is useful for controlling the release of the microorganisms following rehydration and propagation within the particle.

Encapsulated microorganisms and methods of using same

A dehydrated composition containing a particle encapsulating one or more microorganisms is provided. The composition is useful for controlling the release of the microorganisms following rehydration and propagation within the particle.

PVA MEMBRANE IMMOBILIZED ENZYME AND PREPARATION METHOD THEREFOR

Described herein are a PVA membrane immobilized enzyme and a preparation method therefor. The PVA membrane immobilized enzyme includes a PVA porous membrane and an enzyme entrapped on the PVA porous membrane. The PVA porous membrane is a three-dimensional structured PVA porous membrane. The enzyme is any one selected from transaminase, D-lactate dehydrogenase, cyclohexanone monooxygenase, ketoreductase, alkene reductase, nitrilase, ammonia lyase, amino acid dehydrogenase, imine reductase, alcohol dehydrogenase, ammonium formate dehydrogenase, glucose 1-dehydrogenase and mutants thereof. The three-dimensional structured PVA porous membrane is used as a carrier to immobilize an enzyme in an entrapment manner. After entrapping and immobilizing the enzyme in the PVA porous membrane, the enzyme is stable, and cannot be easily leached out in the process of use. The PVA porous membrane is suitable for use in continuous flow biochemical catalysis, and has wide applicability to enzymes.